Given the gut-wrenching financial turmoil of the last year, many investors are looking for more secure ways of investing.

Floyd Brown says one way of doing this is to rethink the “boring” image of dividend-paying stocks. These stocks can offer great returns and a steady cash flow.

Floyd says there are five pharmaceutical companies offering outstanding dividend yields in a growing sector. And with most negative sentiment already priced into the stocks, downside risk is limited…

To see how improving net margin separates winning companies from those merely surviving, there’s no better place to look than food industry.

This industry is getting squeezed, as spiraling commodities prices increase input costs. And few firms are managing to pass those extra costs onto cash-strapped consumers.

One company is bucking that trend, says Lynn Carpenter in Investor’s Daily Edge. Spam-maker Hormel (NYSE:HRL) reported a 17% improvement on its net profits from a year ago…

Editors’ Note: What’s the best-performing US stock for the last half-century?

It’s a blue-chip company. But it’s not a bank. Or a car manufacturer. Or Mircorsoft. Or Google.

In the world of investing, sometimes the separate parts are worth more than the whole. Those parts are called “corporate spin-offs,” and as far as investment plays go, they can be one of the safest and most-profitable hands that investors can play – especially against a market backdrop as uncertain as the one we face now.

The Investment U e-Letter: Issue #783
Monday, April 7, 2008

A Contrarian Strategy: Why Clear Channel Is Today’s Top Stock Pick
by Floyd G. Brown, Advisory Panelist, Investment U

One of the most profitable investments I have made came after a magazine headline hailed the coming bankruptcy of Philip Morris. It took nerves of steel to buy the lowly MO in those days. It was after the largest legal settlement in U.S. history disgorged Morris and other tobacco stocks of profits to pay the healthcare bills of the 50 different United States. Attorney General Janet Reno attacked the company in the newspapers as merchants of death.

But in the eight years since I first bought Philip Morris, at around $19 a share, I have been paid a…